<DOC>
	<DOCNO>NCT00252343</DOCNO>
	<brief_summary>To evaluate efficacy fix dose SR58611A ( 350mg q12 ) compare placebo patient GeneralizedAnxiety Disorder ( GAD ) use escitalopram ( 10 mg qd ) positive control . To evaluate tolerability safety SR58611A patient GAD .</brief_summary>
	<brief_title>Efficacy Safety SR58611A Patients With Generalized Anxiety Disorder</brief_title>
	<detailed_description>The current study conduct evaluate efficacy , safety , tolerability SR58611A ( 350 mg q12 ) compare placebo patient generalize anxiety disorder ( GAD ) , use escitalopram ( 10 mg qd ) positive control . This 8-week , double-blind , randomize , 3-parallel-group , placebo- escitalopram-controlled , study.A 1-week , placebo , single-blind period precedes 8-week randomized treatment period . A Safety Follow Visit ( Segment C ) schedule 1 week acute treatmentperiod ( Segment B ) early termination . This trial design compare efficacy , safety , tolerability SR58611A placebo . In study , escitalopram , selective serotonin reuptake inhibitor ( SSRI ) antidepressant , use positive control choose comparator agentas approve treatment GAD dose 10 mg daily .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Amibegron</mesh_term>
	<criteria>Main inclusion criterion : 1 . Outpatients , 18 year older . 2 . Generalized Anxiety Disorder ( GAD ) accord toDSMIVTR criterion / MINI . 3 . Minimum total score 20 14item HamiltonAnxiety Rating Scale ( HAMA ) Main exclusion criterion : 1 . Patients diagnosis Major Depressive Disorder within 6 month study entry . 2 . Patients MontgomeryAsberg Depression Rating Scale ( MADRS ) total score 18 high 3 . Patients assessed moderate high current risk suicide accord MINI , imminent risk suicide attempt 4 . Patients current anxiety disorder ( within 6 month ) assess MINI : Agoraphobia , social phobia , Panic disorder , Obsessive compulsive disorder , Posttraumatic stress disorder , acute stress disorder . 5 . Patients lifetime history accord MINI : Bipolar disorder , Psychotic disorder , Antisocial Personality Disorder . 6 . Patients current history accord MINI : Anorexia nervosa bulimia nervosa past 6 month , Alcohol dependence abuse substance dependence abuse past 12 month except nicotine caffeine dependence . 7 . Patients receive nonpharmacologic , somatic treatment psychiatric disease 8 . Patients initiated , stop , change frequency nature psychotherapy within 3 month prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>anxiety disorder</keyword>
</DOC>